Table 6.
Adjusted OR and 95% CI for the factors associated with mortality in OPC poisoning patients
| Factor | Survived 375 n (%) |
Expired 66 n (%) |
Adjusted OR (95% CI) | p value |
|---|---|---|---|---|
| Age | ||||
| 18–30 years | 187 (49.87) | 18 (27.27) | Reference category | |
| 31–50 years | 126 (33.60) | 20 (30.30) | 1.455 (0.732–2.892) | 0.285 |
| 50 years above | 62 (16.53) | 28 (42.42) | 4.275 (2.179–8.387) | < 0.001a |
| Gender | ||||
| Female | 126 (33.60) | 10 (15.15) | Reference category | |
| Male | 249 (66.40) | 56 (84.85) | 2.608 (1.258–5.406) | 0.010a |
| Treatment pattern | ||||
| ATR and PAM | 167 (44.53) | 22 (33.33) | Reference category | |
| ATR alone | 115 (30.67) | 19 (28.79) | 1.123 (0.567–2.221 | 0.740 |
| ATR and GPR | 29 (7.73) | 4 (6.06) | 0.757 (0.232–2.468 | 0.644 |
| ATR, PAM and GPR | 64 (17.07) | 21 (31.82) | 2.233 (1.002–4.040) | 0.049a |
OR odds ratio, ATR atropine, PAM pralidoxime, GPR glycopyrrolate
aStatistically significant p < 0.05